Drugs MVST IB - part 1

Random Science or description Quiz

Can you name the drugs from MVST IB - part 1?

Quiz not verified by Sporcle

How to Play
DescriptionDrug nameUse
Binds to synaptobrevin to prevent vesicle release from inhibitory interneuron synapses with motor neurons
Blocks Na channels from exterior - no use-dependence
Indirectly-acting sympathomimetic amine - weak inhibitor of MAO
Orally-acting hypoglycaemic agent - sulphonylurea
Selective antagonist for M1 muscarinic receptors
Blocks transporter carrying ACh into storage vesicles
Involved with providing new blood flow to ischaemic tissues
ADP-ribosylates alpha-s - inhibits GTPase activity - sustained activation of adenylyl cyclase
Class III antidysrhythmic - prolongs AP and refractory period
Nicotinic receptor antagonist - relatively non-selective between NMJ and ganglion at clinical doses
K channel opener - also NO donor
Anion exchange resin - prevents reuptake of bile acids from intestine
Inodilator used to treat canine dilated cardiomyopathy - calcium sensitiser
Used experimentally to inhibit dopamine beta-hydroxylase - also inhibits aldehyde dehyddrogenase
ADP-ribosylates alpha-i - prevents activation of Gi in response to stimulation
Inhibits clotting by inhibiting synthesis of factors II, VII, IX, IX and regulatory proteins C, S, Z
Indirectly acting sympathomimetic amine - converted to octopamine by DBH - found in various foodstuffs
Competitive inhibitor of tyrosine hydroxylase
Tricyclic antidepressant - blocks NET
Binds to plasminogen activator, increasing generation of plasmin
Cardiac glycoside - inhibits Na/K-ATPase
Tyrosine kinase inhibitor
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Beta-1 antagonist used in heart failure
Mild partial beta-1 agonist
Selective alpha-2 agonist
Calcium channel agonist - dihydropyridine
Inhibits HMG-CoA reductase - also many pleiotropic effects
Reverse inhibition of AChE by organophosphorus agents
Phosphodiesterase III inhibitor - inodilator
Monoclonal antibody against glycoprotein IIb/IIIa receptor - prevents platelet aggregation - also binds to vitronectin receptor
Selective alpha-2 antagonist (slight effect on alpha-1)
Muscarinic receptor antagonist - very long duration of action
Double chain recombinant human tissue plasminogen activator
Selective alpha-1 agonist (some action on beta-1)
Experimental cardiac glycoside
Intracellular tetravalent polyamine - helps produce inward rectification of K+ channels
Class IC antidysrhythmic
Irreversible alpha-adrenoceptor antagonist - blocks Uptake 2 (and Uptake 1 at 10x higher concs)
Binds to neurexins, causing massive ACh release from nerve terminals
Irreversible antagonist at nicotinic NMJ receptors (no effect on ganglionic receptors)
Medium 'reversible' anticholinesterase - binds to esteratic site and carbamoylates ACh
Selective beta-2 agonist (slight effect on beta-1)
Estrogen receptor agonist
Selective inhibitor of NOS in neurons
Calcium channel antagonist - dihydropyridine - affects L-type but not T-type channels
Angiotensin II partial agonist
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Co-released with NA or ACh - acts on purinoceptors (P2 > P1)
Cyclic heptapeptide inhibitor of glycoprotein IIb/IIIa receptor
Irreversible anticholinesterase - activated by replacement of sulphur atom with oxygen, deoxified by plasma carboxylesterases
SSRI - blocks 5-HT transporter in Uptake 1
DescriptionDrug nameUse
Inhibits DOPA decarboxylase in periphery
Causes development of new blood vessels
Non-selective beta-adrenoceptor antagonist
Irreversibly alkylates muscarinic receptor
NSAID used to prevent thrombosis
Selective inhibitor of phosphodiesterase type V (selectively breaks down cGMP)
Blocks uptake of choline into neurons
Non-selective phosphodiesterase inhibitor
Blocks release of neurotransmitter via phospholipase A2 - localises to membrane by K channel binding moiety
Acts on imidazoline receptors
A1 receptor antagonist - non-selective phosphodiesterase inhibitor
Very potent alpha-2 agonist
Non-selective agonist for muscarinic receptors
Competitive antagonist for ganglionic nicotinic receptors - inactive at NMJ
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Inhibits intestinal absorption of cholesterol - circulates enterohepatically
K channel opener
Progestagen receptor antagonist
Competitive antagonist for ganglionic nicotinic receptor - inactive at NMJ
Regulates expression of multiple angiogenic genes
K channel opener - also hirsutism effects
Partial agonist at alpha-adrenoceptors - 5-HT agonist
Mineralocorticoid receptor agonist
Glucocorticoid receptor agonist
Direct acting vasodilator - metabolised to NO or cyanide
Local anaesthetic - uncharged
Calcium sensitiser - increases cardiac Ca2+ binding efficiency to troponin - inhibits phosphodiesterase III
PPAR-gamma agonist
Non-selective, reversible MAO inhibitor
Orally-acting hypoglycaemic agent - sulphonylurea
Depolarising blocker selective for ganglion nicotinic receptor
Irreversible anticholinesterase - organophosphorus agent
Nitrovasodilator - produces NO - metabolised in liver to active drug
Lowers VLDL (and LDL) by stimulating lipoprotein lipase - may activate PPARs
Non-selective alpha-adrenoceptor antagonist
Single chain recombinant human tissue plasminogen activator
Phosphodiesterase III inhibitor - inodilator
Depolarising blocker selective for NMJ nicotinic receptor - very short duration of action, broken down by BuChe - deficiency in enzyme activity can lead to prolonged action
Naturally occurring anticoagulant produced by basophils/mast cells - exposes active site of antithrombin III
Non-selective phosphodiesterase inhibitor
Selective antagonist for M3 muscarinic receptor
Selective beta-1 antagonist (slight effect on beta-2)
NOS inhibitor - not very selective for different forms
Inhibits platelet activation by inhibiting binding of ADP to its receptor on platelets
Non-peptide angiotensin II antagonist - acts on AT1 receptors
Potent, irreversible inhibitor of iNOS in activated macrophages
Selective MAO-A inhibitor
Cholinergic agonist - not selective between nicotinic/muscarinic receptors
Non-specific endothelin receptor antagonist
Uncompetitive inhibitor of phosphatase acting on IP1 --> inositol
Use-dependent block of ganglionic transmission
Binds very tightly to VMAT-2, preventing loading of catecholamines into vesicles
DescriptionDrug nameUse
Selective non-depolarising neuromuscular blocking agent at NMJ - long action, not hydrolysed
Cholinergic agonist - +-isomer hydrolysed by AChE
Arteriolar vasodilator - unknown mechanism
Interferes with normal function of microtubule growth
Glucocorticoid receptor antagonist
Beta-adrenoceptor agonist
Nitrovasodilator - produces NO - taken sublingually
Combined alpha- and beta-adrenoceptor antagonist
Beta-1 agonist - weak beta-2 agonist
Estrogen receptor antagonist
Selective beta-2 antagonist (slight effect on beta-1)
K channel opener
Thiazide diuretic - blocks Na/Cl transport in early distal tubule
Local anaesthetic - weak base - use-dependence and voltage-dependence
Immunosuppressant drug with antiproliferative effects
Mineralocorticoid receptor antagonist - potassium-sparing diuretic
Progestagen receptor agonist
Local anaesthetic - slow onset/offset - use dependence at low rates of stimulation - class IA antidysrhythmic
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Local anaesthetic (ester, weak base) - broken down by BuChE
Loop diuretic - blocks Na/K/2Cl transport in thick ascending limb
Calcium channel blocker - phenylalkylamine - class IV antidysrhythmic
Binds to SNAREs involved in membrane fusion, preventing ACh release
Plasminogen + anisoylated streptokinase
Non-selective agonist for muscarnic receptors
Converted to alpha-methylNA - released as false transmitter - more potent at alpha-2, less potent at alpha-1
ACE inhibitor - prodrug, must be metabolised in liver
Osmotic diuretic - filtered at glomerulus, not reabsorbed
Blocks transport of adenosine into cells - phosphodiesterase type V inhibitor
COMT inhibitor
Illegal drug - blocks NET
Non-peptide inhibitor of glycoprotein IIb/IIIa receptor
Selective MAO-B inhibitor
Depolarising blocker at NMJ
alpha-1 antagonist most commonly used
Blocks If current in SA node
Slightly selective alpha-2 agonist (also alpha-1 actions) - omitting dose can lead to rebound hypertension
Acts on imidazoline receptors
Muscarinic receptor agonist
Calcium channel blocker - benzothiazepine
ACE inhibitor
Selective alpha-1 antagonist (slight effect on alpha-2)
Inhibits liver triglyceride production and VLDL secretion - increases levels of tissue plasminogen activator
Nitrovasodilator - produces NO
Quaternary local anaesthetic analogue - only effective if perfused inside cells
Tricyclic antidepressant - blocks NET
Reversible anticholinesterase - ionic interaction
Beta-1 antagonist used in heart failure
Alpha-2 antagonist (some effect on alpha-1)
Carbonic anhydrase inhibitor
Blocks release of NA evoked by APs (repeated low doses/aftermath of large dose) - indirect sympathomimetic actions (large doses)
Selective non-depolarising neuromuscular blocker at NMJ - ester, broken down by spontaneous hydrolysis and plasma esterases

Friend Scores

  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...


Created May 3, 2010ReportNominate
Tags:description, drug